Article abstract
Nature Cell Biology 8, 815 - 825 (2006)
Published online: 23 July 2006 | doi:10.1038/ncb1438
There is an Erratum (September 2006) associated with this Article.
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway
Nicole K. Noren1, Gabriele Foos1, Craig A. Hauser1 & Elena B. Pasquale1,2
Abstract
Recent evidence supports a role for EphB receptor tyrosine kinases as tumour suppressors in colorectal and prostate cancer. However, it is unclear how these receptors inhibit cancer cell tumorigenicity — an activity that is highly unusual for a family of receptor tyrosine kinases. Here, we report that the EphB4 receptor can behave as a tumour suppressor in a mouse xenograft model of breast cancer when stimulated by its ligand, ephrin-B2. In breast cancer cells, EphB4 activates an antioncogenic pathway involving Abl family tyrosine kinases and the Crk adaptor protein. This Abl–Crk pathway inhibits breast cancer cell viability and proliferation in addition to motility and invasion, and also downregulates the pro-invasive matrix metalloprotease, MMP-2. Consistent with these effects, EphB4 and the Abl–Crk pathway are constitutively active in non-transformed mammary epithelial cells. These findings identify a novel Eph receptor signalling pathway with tumour-suppressor activity and predict that therapeutic intervention to activate EphB4 signalling will inhibit tumour progression.
- Burnham Institute for Medical Research, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
- Pathology Department, University of California San Diego, La Jolla, CA 92093, USA.
Correspondence to: Elena B. Pasquale1,2 e-mail: elenap@burnham.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Eph tumour suppression: the dark side of GleevecNature Cell Biology News and Views (01 Aug 2006)
Ephrins keep dendritic spines in shapeNature Neuroscience News and Views (01 Feb 2003)
See all 5 matches for News And ViewsRESEARCH
EphB?ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cellsNature Genetics Letter (01 Nov 2007)
See all 44 matches for Research
